HLA and the Pharmacogenomics of Drug Hypersensitivity

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  2014-05-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-0-12-386882-4.00021-9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• HLA Allelic Variants and Carbamazepine‐Induced Hypersensitivity

  2013cited by this paper
• Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population

  2013cited by this paper
• Testing for drug hypersensitivity syndromes.

  2013cited by this paper
• Specific HLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects.

  2013cited by this paper
• Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen‐B Genotype and Allopurinol Dosing

  2013cited by this paper
• HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in children

  2013cited by this paper
• Associations Between HLA-DRB1*0102, HLA-B*5801, and Hepatotoxicity During Initiation of Nevirapine-Containing Regimens in South Africa

  2013cited by this paper
• HLA-B*57:01(+) abacavir-naive individuals have specific T cells but no patch test reactivity.

  2013cited by this paper
• HLA-B*13:01 and the dapsone hypersensitivity syndrome.

  2013cited by this paper
• HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity

  2013cited by this paper
• Case of carbamazepine‐induced hypersensitivity syndrome associated with human leukocyte antigen‐A*3101

  2012cited by this paper
• Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA‐B Genotype and Carbamazepine Dosing

  2012cited by this paper
• Association between HLA and Stevens–Johnson Syndrome Induced by Carbamazepine in Southern Han Chinese: Genetic Markers besides B*1502?

  2012cited by this paper
• HLA and pharmacogenetics of drug hypersensitivity.

  2012cited by this paper
• Abacavir induces loading of novel self-peptides into HLA-B*57: 01 an autoimmune model for HLA-associated drug hypersensitivity

  2012cited by this paper
• HLA‐A31 strongly associates with carbamazepine‐induced adverse drug reactions but not with carbamazepine‐induced lymphocyte proliferation in a Japanese population

  2012cited by this paper
• HLA-Dependent Hypersensitivity Reaction to Nevirapine in Chinese Han HIV-Infected Patients

  2012cited by this paper
• HLA‐B*1502 Strongly Predicts Carbamazepine‐Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain

  2012cited by this paper
• Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.

  2012cited by this paper
• HLA Genotype and Carbamazepine‐Induced Cutaneous Adverse Drug Reactions: A Systematic Review

  2012cited by this paper
• Tag SNPs of the ancestral haplotype 57.1 do not substitute HLA-B*57:01 typing for eligibility to abacavir treatment in the Italian population.

  2012cited by this paper
• Association between HLA‐B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong

  2012cited by this paper
• Avidity determines T‐cell reactivity in abacavir hypersensitivity

  2012cited by this paper
• Copy Number Variation and Incomplete Linkage Disequilibrium Interfere with the HCP5 Genotyping Assay for Abacavir Hypersensitivity

  2012cited by this paper
• Genetic association studies in drug-induced liver injury

  2012cited by this paper
• Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions – A Meta-Analysis

  2012cited by this paper
• Immune self-reactivity triggered by drug-modified HLA-peptide repertoire

  2012cited by this paper
• Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

  2012cited by this paper
• Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.

  2012cited by this paper
• Drug-induced liver injury

  2012cited by this paper
• Conformational variation in structures of classical and non‐classical MHCII proteins and functional implications

  2012cited by this paper
• The structural basis of HLA‐associated drug hypersensitivity syndromes

  2012cited by this paper
• Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans.

  2011cited by this paper
• Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.

  2011cited by this paper
• Phenotype Standardization for Immune‐Mediated Drug‐Induced Skin Injury

  2011cited by this paper
• HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer.

  2011cited by this paper
• Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics.

  2011cited by this paper
• Pharmacogenetics: From Bench to Byte— An Update of Guidelines

  2011cited by this paper
• Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe

  2011cited by this paper
• A whole-genome association study of major determinants for allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese patients

  2011cited by this paper
• Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.

  2011cited by this paper
• Genome-wide association study identifies variations in 6p21.3 associated with nevirapine-induced rash.

  2011cited by this paper
• Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients.

  2011cited by this paper
• Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.

  2011cited by this paper
• HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency.

  2011cited by this paper
• Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients

  2011cited by this paper
• TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition

  2011cited by this paper
• Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans

  2011cited by this paper
• Hla-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population.

  2011cited by this paper
• Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis.

  2011cited by this paper
• Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland.

  2011cited by this paper
• Psoriasis-Associated Genetic Polymorphism in North Indian Population in the CCHCR1 Gene and in a Genomic Segment Flanking the HLA-C Region

  2011cited by this paper
• Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent

  2011cited by this paper
• A new approach to safely type for HLA the HIV infected people eligible to abacavir therapy: saliva or buccal swab as reliable DNA sources.

  2011cited by this paper
• Association of HLA‐B*1502 allele with carbamazepine‐induced toxic epidermal necrolysis and Stevens–Johnson syndrome in the multi‐ethnic Malaysian population

  2011cited by this paper
• HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.

  2011cited by this paper
• Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis

  2011cited by this paper
• Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivity.

  2011cited by this paper
• Signatures of historical demography and pathogen richness on MHC class I genes

  2011cited by this paper
• HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.

  2010cited by this paper
• HLA‐B*1511 is a risk factor for carbamazepine‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis in Japanese patients

  2010cited by this paper
• Nevirapine‐associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya

  2010cited by this paper
• OC-035 Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a diagnostic test accuracy meta-analysis

  2010cited by this paper
• Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.

  2010cited by this paper
• HLA Class I markers in Japanese patients with carbamazepine‐induced cutaneous adverse reactions

  2010cited by this paper
• Association between HLA‐B*1502 and carbamazepine‐induced severe cutaneous adverse drug reactions in a Thai population

  2010cited by this paper
• Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.

  2010cited by this paper
• Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.

  2010cited by this paper
• Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population.

  2010cited by this paper
• HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity

  2010cited by this paper
• HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

  2009cited by this paper
• Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians.

  2009cited by this paper
• Oxcarbazepine‐induced Stevens‐Johnson Syndrome: A Case Report

  2009cited by this paper
• Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population

  2009cited by this paper
• HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients

  2009cited by this paper
• Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure.

  2009cited by this paper
• Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition

  2009cited by this paper
• HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients

  2009cited by this paper
• Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy

  2009cited by this paper
• The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir.

  2008cited by this paper
• Drug-induced lupus erythematosus

  2008cited by this paper
• Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.

  2008cited by this paper
• Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies

  2008cited by this paper
• HLA associations in aurothioglucose- and D-penicillamine-induced haematotoxic reactions in rheumatoid arthritis.

  2008cited by this paper
• Flucloxacillin-induced liver injury.

  2008cited by this paper
• Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

  2008cited by this paper
• Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.

  2008cited by this paper
• BAT1 promoter polymorphism is associated with rheumatoid arthritis susceptibility.

  2008cited by this paper
• HLA class I supertypes: a revised and updated classification

  2008cited by this paper
• HLA-B*5701 screening for hypersensitivity to abacavir.

  2008cited by this paper
• High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients.

  2008cited by this paper
• Genetic factors predicting abacavir hypersensitivity and tolerance in HLA-B*5701 positive individuals

  2008cited by this paper
• HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz

  2008cited by this paper
• Carbamazepine and phenytoin induced Stevens‐Johnson syndrome is associated with HLA‐B*1502 allele in Thai population

  2008cited by this paper
• Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study.

  2008cited by this paper
• A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

  2008cited by this paper
• HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis.

  2008cited by this paper
• Pharmacogenetics of aspirin-intolerant asthma.

  2008cited by this paper
• Association of human herpesvirus 6 reactivation with the flaring and severity of drug‐induced hypersensitivity syndrome

  2007cited by this paper
• Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.

  2007cited by this paper

• Why drug exposure is frequently associated with T-cell mediated cutaneous hypersensitivity reactions

  2023cites this paper
• A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine

  2021cites this paper
• Genetic Diversity of HLA Class I and Class II Alleles in Thai Populations: Contribution to Genotype-Guided Therapeutics

  2020cites this paper
• Immune Mechanisms of Drug Allergy

  2018cites this paper
• HLAs: Key regulators of T‐cell‐mediated drug hypersensitivity

  2018cites this paper
• Critical assessment of approaches for molecular docking to elucidate associations of HLA alleles with adverse drug reactions

  2018cites this paper
• Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.

  2015cites this paper
• The evolving story of human leukocyte antigen and the immunogenetics of peanut allergy.

  2015cites this paper
• PharmGKB summary: very important pharmacogene information for human leukocyte antigen B

  2015cites this paper